Scott Harris
Company: Altimmune
Job title: Chief Medical Officer
Seminars:
Unlocking Glucagon Biology to Overcome Fibrosis in MASH 1:50 pm
Understanding the therapeutic benefit of glucagon-based agents on serum and hepatic lipids Navigating Pemvitutide Phase 2b trial data Analyzing the effect on inflammation, LDL cholesterol and body compositionRead more
day: Conf Day 1 Track 2 PM